Skip to main content
NCBI home page
British Heart Journal logoLink to British Heart Journal
. 1995 May;73(5):397–400. doi: 10.1136/hrt.73.5.397

ACE inhibitors after myocardial infarction: patient selection or treatment for all?

H S Lindsay 1, A G Zaman 1, J C Cowan 1
PMCID: PMC483845  PMID: 7786645

Full text

PDF
397

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ganley C. J., Hung H. M., Temple R. More on the survival and ventricular enlargement trial. N Engl J Med. 1993 Oct 14;329(16):1204–1206. doi: 10.1056/nejm199310143291616. [DOI] [PubMed] [Google Scholar]
  2. Gaudron P., Eilles C., Kugler I., Ertl G. Progressive left ventricular dysfunction and remodeling after myocardial infarction. Potential mechanisms and early predictors. Circulation. 1993 Mar;87(3):755–763. doi: 10.1161/01.cir.87.3.755. [DOI] [PubMed] [Google Scholar]
  3. Hall A. S., Tan L. B., Gray D., Ball S. G. ACE inhibitors for myocardial infarction and unstable angina. Lancet. 1992 Dec 19;340(8834-8835):1548–1548. [PubMed] [Google Scholar]
  4. Kleist P. ACE inhibitors after myocardial infarction. Lancet. 1994 Jun 25;343(8913):1633–1634. [PubMed] [Google Scholar]
  5. Motwani J. G., McAlpine H., Kennedy N., Struthers A. D. Plasma brain natriuretic peptide as an indicator for angiotensin-converting-enzyme inhibition after myocardial infarction. Lancet. 1993 May 1;341(8853):1109–1113. doi: 10.1016/0140-6736(93)93126-l. [DOI] [PubMed] [Google Scholar]
  6. Pfeffer M. A., Braunwald E., Moyé L. A., Basta L., Brown E. J., Jr, Cuddy T. E., Davis B. R., Geltman E. M., Goldman S., Flaker G. C. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators. N Engl J Med. 1992 Sep 3;327(10):669–677. doi: 10.1056/NEJM199209033271001. [DOI] [PubMed] [Google Scholar]
  7. Pfeffer M. A., Lamas G. A., Vaughan D. E., Parisi A. F., Braunwald E. Effect of captopril on progressive ventricular dilatation after anterior myocardial infarction. N Engl J Med. 1988 Jul 14;319(2):80–86. doi: 10.1056/NEJM198807143190204. [DOI] [PubMed] [Google Scholar]
  8. Ray S. G., Metcalfe M. J., Oldroyd K. G., Pye M., Martin W., Christie J., Dargie H. J., Cobbe S. M. Do radionuclide and echocardiographic techniques give a universal cut off value for left ventricular ejection fraction that can be used to select patients for treatment with ACE inhibitors after myocardial infarction? Br Heart J. 1995 May;73(5):466–469. doi: 10.1136/hrt.73.5.466. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Ray S. G., Pye M., Oldroyd K. G., Christie J., Connelly D. T., Northridge D. B., Ford I., Morton J. J., Dargie H. J., Cobbe S. M. Early treatment with captopril after acute myocardial infarction. Br Heart J. 1993 Mar;69(3):215–222. doi: 10.1136/hrt.69.3.215. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Sharpe N. Myocardial infarction and heart failure. The common ground. Circulation. 1993 Mar;87(3):1037–1039. doi: 10.1161/01.cir.87.3.1037. [DOI] [PubMed] [Google Scholar]
  11. Sharpe N., Smith H., Murphy J., Greaves S., Hart H., Gamble G. Early prevention of left ventricular dysfunction after myocardial infarction with angiotensin-converting-enzyme inhibition. Lancet. 1991 Apr 13;337(8746):872–876. doi: 10.1016/0140-6736(91)90202-z. [DOI] [PubMed] [Google Scholar]
  12. St John Sutton M., Pfeffer M. A., Plappert T., Rouleau J. L., Moyé L. A., Dagenais G. R., Lamas G. A., Klein M., Sussex B., Goldman S. Quantitative two-dimensional echocardiographic measurements are major predictors of adverse cardiovascular events after acute myocardial infarction. The protective effects of captopril. Circulation. 1994 Jan;89(1):68–75. doi: 10.1161/01.cir.89.1.68. [DOI] [PubMed] [Google Scholar]
  13. Swedberg K., Held P., Kjekshus J., Rasmussen K., Rydén L., Wedel H. Effects of the early administration of enalapril on mortality in patients with acute myocardial infarction. Results of the Cooperative New Scandinavian Enalapril Survival Study II (CONSENSUS II) N Engl J Med. 1992 Sep 3;327(10):678–684. doi: 10.1056/NEJM199209033271002. [DOI] [PubMed] [Google Scholar]
  14. Underwood R., Gibson C., Tweddel A., Flint J. A survey of nuclear cardiological practice in Great Britain. The British Nuclear Cardiology Group. Br Heart J. 1992 Mar;67(3):273–277. doi: 10.1136/hrt.67.3.273. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. White H. D., Cross D. B., Elliott J. M., Norris R. M., Yee T. W. Long-term prognostic importance of patency of the infarct-related coronary artery after thrombolytic therapy for acute myocardial infarction. Circulation. 1994 Jan;89(1):61–67. doi: 10.1161/01.cir.89.1.61. [DOI] [PubMed] [Google Scholar]
  16. White H. D., Norris R. M., Brown M. A., Brandt P. W., Whitlock R. M., Wild C. J. Left ventricular end-systolic volume as the major determinant of survival after recovery from myocardial infarction. Circulation. 1987 Jul;76(1):44–51. doi: 10.1161/01.cir.76.1.44. [DOI] [PubMed] [Google Scholar]
  17. Yusuf S., Pepine C. J., Garces C., Pouleur H., Salem D., Kostis J., Benedict C., Rousseau M., Bourassa M., Pitt B. Effect of enalapril on myocardial infarction and unstable angina in patients with low ejection fractions. Lancet. 1992 Nov 14;340(8829):1173–1178. doi: 10.1016/0140-6736(92)92889-n. [DOI] [PubMed] [Google Scholar]
  18. Zaman A. G., Morris J. L., Smyllie J. H., Cowan J. C. Late potentials and ventricular enlargement after myocardial infarction. A new role for high-resolution electrocardiography? Circulation. 1993 Sep;88(3):905–914. doi: 10.1161/01.cir.88.3.905. [DOI] [PubMed] [Google Scholar]

Articles from British Heart Journal are provided here courtesy of BMJ Publishing Group

RESOURCES